SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation

Summary: Neurodegenerative disorders are an increasingly common and irreversible burden on society, often affecting the aging population, but their etiology and disease mechanisms are poorly understood. Studying monogenic neurodegenerative diseases with known genetic cause provides an opportunity to...

Full description

Bibliographic Details
Main Authors: Javier Calvo-Garrido, Camilla Maffezzini, Florian A. Schober, Paula Clemente, Elias Uhlin, Malin Kele, Henrik Stranneheim, Nicole Lesko, Helene Bruhn, Per Svenningsson, Anna Falk, Anna Wedell, Christoph Freyer, Anna Wredenberg
Format: Article
Language:English
Published: Elsevier 2019-04-01
Series:Stem Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213671119300256
id doaj-325a48b5ac9c47b4bce704a2ebf2353e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Javier Calvo-Garrido
Camilla Maffezzini
Florian A. Schober
Paula Clemente
Elias Uhlin
Malin Kele
Henrik Stranneheim
Nicole Lesko
Helene Bruhn
Per Svenningsson
Anna Falk
Anna Wedell
Christoph Freyer
Anna Wredenberg
spellingShingle Javier Calvo-Garrido
Camilla Maffezzini
Florian A. Schober
Paula Clemente
Elias Uhlin
Malin Kele
Henrik Stranneheim
Nicole Lesko
Helene Bruhn
Per Svenningsson
Anna Falk
Anna Wedell
Christoph Freyer
Anna Wredenberg
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
Stem Cell Reports
author_facet Javier Calvo-Garrido
Camilla Maffezzini
Florian A. Schober
Paula Clemente
Elias Uhlin
Malin Kele
Henrik Stranneheim
Nicole Lesko
Helene Bruhn
Per Svenningsson
Anna Falk
Anna Wedell
Christoph Freyer
Anna Wredenberg
author_sort Javier Calvo-Garrido
title SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
title_short SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
title_full SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
title_fullStr SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
title_full_unstemmed SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
title_sort sqstm1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation
publisher Elsevier
series Stem Cell Reports
issn 2213-6711
publishDate 2019-04-01
description Summary: Neurodegenerative disorders are an increasingly common and irreversible burden on society, often affecting the aging population, but their etiology and disease mechanisms are poorly understood. Studying monogenic neurodegenerative diseases with known genetic cause provides an opportunity to understand cellular mechanisms also affected in more complex disorders. We recently reported that loss-of-function mutations in the autophagy adaptor protein SQSTM1/p62 lead to a slowly progressive neurodegenerative disease presenting in childhood. To further elucidate the neuronal involvement, we studied the cellular consequences of loss of p62 in a neuroepithelial stem cell (NESC) model and differentiated neurons derived from reprogrammed p62 patient cells or by CRISPR/Cas9-directed gene editing in NESCs. Transcriptomic and proteomic analyses suggest that p62 is essential for neuronal differentiation by controlling the metabolic shift from aerobic glycolysis to oxidative phosphorylation required for neuronal maturation. This shift is blocked by the failure to sufficiently downregulate lactate dehydrogenase expression due to the loss of p62, possibly through impaired Hif-1α downregulation and increased sensitivity to oxidative stress. The findings imply an important role for p62 in neuronal energy metabolism and particularly in the regulation of the shift between glycolysis and oxidative phosphorylation required for normal neurodifferentiation. : SQSTM1/p62 is a known autophagy adaptor that, if lost, causes childhood-onset neurodegeneration. Data from Wredenberg et al. show that loss of p62 in a neuronal stem cell model does not affect mitophagy but instead leads to impaired differentiation. The authors suggest p62 finely tunes LDHA expression and thus controls the metabolic shift to OXPHOS required for proper differentiation. Keywords: SQSTM1, p62, hypoxia, mitochondria, neurodifferentiation, neuroepithelial-like stem cells, neuronal development, oxidative stress, mitophagy, neurodegeneration
url http://www.sciencedirect.com/science/article/pii/S2213671119300256
work_keys_str_mv AT javiercalvogarrido sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT camillamaffezzini sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT florianaschober sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT paulaclemente sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT eliasuhlin sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT malinkele sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT henrikstranneheim sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT nicolelesko sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT helenebruhn sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT persvenningsson sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT annafalk sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT annawedell sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT christophfreyer sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
AT annawredenberg sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation
_version_ 1725437834349772800
spelling doaj-325a48b5ac9c47b4bce704a2ebf2353e2020-11-25T00:02:25ZengElsevierStem Cell Reports2213-67112019-04-01124696711SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal NeurodifferentiationJavier Calvo-Garrido0Camilla Maffezzini1Florian A. Schober2Paula Clemente3Elias Uhlin4Malin Kele5Henrik Stranneheim6Nicole Lesko7Helene Bruhn8Per Svenningsson9Anna Falk10Anna Wedell11Christoph Freyer12Anna Wredenberg13Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, SwedenDepartment of Neuroscience, Karolinska Institutet, 171 65 Stockholm, SwedenDepartment of Neuroscience, Karolinska Institutet, 171 65 Stockholm, SwedenDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, SwedenDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, SwedenDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, SwedenDepartment of Clinical Neuroscience, Karolinska Institutet, 171 76 Stockholm, SwedenDepartment of Neuroscience, Karolinska Institutet, 171 65 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, Sweden; Corresponding authorMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, Sweden; Corresponding authorSummary: Neurodegenerative disorders are an increasingly common and irreversible burden on society, often affecting the aging population, but their etiology and disease mechanisms are poorly understood. Studying monogenic neurodegenerative diseases with known genetic cause provides an opportunity to understand cellular mechanisms also affected in more complex disorders. We recently reported that loss-of-function mutations in the autophagy adaptor protein SQSTM1/p62 lead to a slowly progressive neurodegenerative disease presenting in childhood. To further elucidate the neuronal involvement, we studied the cellular consequences of loss of p62 in a neuroepithelial stem cell (NESC) model and differentiated neurons derived from reprogrammed p62 patient cells or by CRISPR/Cas9-directed gene editing in NESCs. Transcriptomic and proteomic analyses suggest that p62 is essential for neuronal differentiation by controlling the metabolic shift from aerobic glycolysis to oxidative phosphorylation required for neuronal maturation. This shift is blocked by the failure to sufficiently downregulate lactate dehydrogenase expression due to the loss of p62, possibly through impaired Hif-1α downregulation and increased sensitivity to oxidative stress. The findings imply an important role for p62 in neuronal energy metabolism and particularly in the regulation of the shift between glycolysis and oxidative phosphorylation required for normal neurodifferentiation. : SQSTM1/p62 is a known autophagy adaptor that, if lost, causes childhood-onset neurodegeneration. Data from Wredenberg et al. show that loss of p62 in a neuronal stem cell model does not affect mitophagy but instead leads to impaired differentiation. The authors suggest p62 finely tunes LDHA expression and thus controls the metabolic shift to OXPHOS required for proper differentiation. Keywords: SQSTM1, p62, hypoxia, mitochondria, neurodifferentiation, neuroepithelial-like stem cells, neuronal development, oxidative stress, mitophagy, neurodegenerationhttp://www.sciencedirect.com/science/article/pii/S2213671119300256